Stockreport

Pansend Life Sciences' Portfolio Company, R2 Technologies, Receives Additional $10 Million Equity Investment From Huadong Medicine Company Limited

HC2 Holdings, Inc.  (HCHC) 
NASDAQ:AMEX Investor Relations: ir.hc2.com
PDF NEW YORK, April 23, 2020 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. (“HC2”) (NYSE: HCHC), a diversified holding company, announced today that R2 Technologies (“R2”), a pri [Read more]